Dynamic contrast-enhanced MRI in malignant pleural mesothelioma: prediction of outcome based on DCE-MRI measurements in patients undergoing cytotoxic chemotherapy

BACKGROUND: The malignant pleural mesothelioma (MPM) response rate to chemotherapy is low. The identification of imaging biomarkers that could help guide the most effective therapy approach for individual patients is highly desirable. Our aim was to investigate the dynamic contrast-enhanced (DCE) MR...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivoda Tomšič, Martina, Korošec, Peter, Kovač, Viljem, Bisdas, Sotirios, Šurlan Popovič, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859879/
https://www.ncbi.nlm.nih.gov/pubmed/35184730
http://dx.doi.org/10.1186/s12885-022-09277-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859879/
https://www.ncbi.nlm.nih.gov/pubmed/35184730
http://dx.doi.org/10.1186/s12885-022-09277-x

Ejemplares similares